Keymed Biosciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	16,070	8,516	13,586	14,174	9,651	-
Market Cap Growth	96.33%	-37.32%	-4.15%	46.87%	-	-
Enterprise Value	13,963	6,526	10,725	10,331	15,170	-
Last Close Price	54.55	30.90	49.10	51.00	34.50	-
PS Ratio	16.81	18.69	34.83	125.30	71.30	-
PB Ratio	4.59	3.23	4.13	3.76	2.16	-
P/TBV Ratio	4.60	3.25	4.13	3.76	2.15	-
EV/Sales Ratio	14.61	14.32	27.49	91.33	112.08	-
Debt / Equity Ratio	0.27	0.30	0.14	0.04	0.01	-1.33
Net Debt / Equity Ratio	-0.60	-0.57	-0.77	-0.91	-0.96	-1.00
Net Debt / EBITDA Ratio	6.65	2.55	5.67	5.85	10.02	-8.13
Net Debt / FCF Ratio	2.25	1.41	3.37	4.49	9.02	-7.89
Asset Turnover	0.21	0.11	0.09	0.03	0.05	-
Inventory Turnover	0.32	0.13	0.66	0.07	1.02	-
Quick Ratio	3.66	3.04	8.80	8.45	31.55	4.42
Current Ratio	3.95	3.30	9.36	8.72	31.96	4.75
Return on Equity (ROE)	-8.82%	-18.85%	-11.31%	-8.69%	-305.24%	-
Return on Assets (ROA)	-5.44%	-10.23%	-7.32%	-8.65%	-10.09%	-15.67%
Return on Capital Employed (ROCE)	-9.60%	-20.70%	-12.80%	-15.30%	-9.40%	-33.10%
Earnings Yield	-1.75%	-6.44%	-2.91%	-2.46%	-49.44%	-
FCF Yield	-5.83%	-12.46%	-5.53%	-5.43%	-4.92%	-
Buyback Yield / Dilution	-0.70%	-0.22%	-0.09%	-62.34%	-139.72%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.